Katherine Unger Baillie
Senior Science News Officer
Katherine Unger Baillie covers the School of Veterinary Medicine, the School of Dental Medicine, and in the School of Arts and Sciences, manages media relations for biology, earth and environmental science, and history and sociology of science. She also occasionally covers scientific research coming from other parts of Penn.
These overlooked global diseases take a turn under the microscope
Faculty at the School of Veterinary Medicine target neglected tropical diseases with advanced science, cross-disciplinary collaborations, and work in the lab and the field.
This Penn heart patient is a 9-year-old boxer dog named Sophie
Sophie underwent a cardiac ablation procedure in a Perelman School of Medicine translational research lab to treat her arrhythmia—the first time a dog with her diagnosis received such a treatment. Veterinary cardiologist Anna Gelzer says of the collaboration, “It’s the best of both worlds.”
Immersive stories to spur action on climate
Organized by the Penn Program in Environmental Humanities (PPEH), a two-day festival, “Environmental Storytelling and Virtual Reality” begins Friday, and will explore how virtual reality and other immersive storytelling might inspire action on climate change.
Mentoring circles support a journey through STEM
An initiative of the Biomedical Postdoctoral Council Diversity Committee has established an informal network of “mentoring circles” for postdocs, graduate students, and undergraduates in STEM, with a particular emphasis on including participants from underrepresented backgrounds.
Campus orchard grows, with help from the community
Now five years old, the Penn Park Orchard is expanding, literally and figuratively. With shovels and sweat equity, members of the University contributed to those efforts at a workday.
The science of sensations
To confront the ills of the opioid epidemic, scientists must develop a fundamental understanding of the biology of pain. Biologist Ishmail Abdus-Saboor’s work is setting the stage for screening alternative drugs and uncovering new pathways that an opioid-alternative could target.